# SAD/MAD Study in Healthy Subjects and Adults With UC to Evaluate Safety, Tolerability, PK, PD of AMT-101

> **NCT04224857** · PHASE1 · COMPLETED · sponsor: **Applied Molecular Transport** · enrollment: 52 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** AMT-101
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04224857
- **Lead sponsor:** Applied Molecular Transport
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2020-04-30
- **Final completion:** 2020-04-30
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2020-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04224857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04224857, "SAD/MAD Study in Healthy Subjects and Adults With UC to Evaluate Safety, Tolerability, PK, PD of AMT-101". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04224857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*